Hutch News

Hutch News

Stories tagged 'survival rate'

How mutations in a single gene alter the course of a deadly brain cancer

New laboratory study of glioma links more aggressive immune response to poorer prognosis

May 23, 2017 | By Sabrina Richards / Fred Hutch News Service

A new study in the aggressive brain cancer known as glioma found that higher levels of immune cells correlated with poorer survival.

View story >


Patients treated at cancer centers live longer: study

Finding of survival-rate differences between cancer hubs and community hospitals spurs call to ‘figure out the gaps’

Nov. 6, 2015 | By Bill Briggs / Fred Hutch News Service

Patients treated at one of 11 specialized cancer centers had higher survival rates compared to cancer patients treated at community hospitals, a study found.

View story >


Immunotherapy for pancreatic cancer boosts survival more than 75 percent in mice, study finds

Therapy using engineered immune cells offers promise for the ‘disease that desperately needs something new’

Oct. 29, 2015 | By Dr. Rachel Tompa / Fred Hutch News Service

A certain type of immunotherapy can boost survival from the nearly-always deadly pancreatic cancer by more than 75 percent in mice, a new study finds.

View story >


Potential breakthrough in pancreatic cancer treatment

Sunil Hingorani-led study breaks unique tumor defense, extends survival in mice by 70 percent; initial human studies under way

March 19, 2012 | By Dean Forbes

Pancreatic cancer tumors spread quickly and are notoriously resistant to treatment, making them among the deadliest of malignancies. Their resistance to chemotherapy stems in part from a unique biological barrier the tumor builds around itself. Now scientists at the Fred Hutchinson Cancer Research Center have found a way to break through that defense, and their research represents a potential breakthrough in the treatment of pancreatic cancer.

View story >


SCCA survival rates top most cancer programs nationwide

According to data compiled by the National Cancer Data Base, survival rates among patients treated for eight types of cancer top other programs accredited by Commission on Cancer

Feb. 21, 2012 | By Dean Forbes

Five-year survival rates among patients treated by Seattle Cancer Care Alliance for eight types of cancer are higher than for patients treated at the other cancer programs accredited by the Commission on Cancer of the American College of Surgeons. The National Cancer Data Base (NCDB), which is operated jointly by the commission with the American Cancer Society, compiled the survival rate data.

View story >


Transplantation refinements boost long-term survival of blood cancers

Clinical Research Division study shows 41 percent drop in post-transplant deaths compared to mid-1990s

Nov. 29, 2010 | By Dean Forbes

Refinements over the last 10 years in marrow and stem cell transplantation to treat blood cancers significantly reduced the risk of treatment-related complications and death, according to an institutional self-analysis of transplant-patient outcomes conducted at the Fred Hutchinson Cancer Research Center.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.